1/49
Looks like no tags are added yet.
peptic ulcer disease
an ulceration of the mucosa within the GI tract that extend deeper into the mucosa; differs from gastritis and erosion because ulcers are > 5 mm
1. H. pylori positive
2. NSAID-induced
3. Stress-related mucosal damage (SRMD)
What are the 3 common forms of peptic ulcers?
mainly duodenum; stomach as well
what is the main site of damage in H. pylori-induced PUD?
mainly stomach
what is the main site of damage in NSAID-induced PUD and SRMD?
H. pylori
Which cause of PUD is more dependent on intragastric pH?
SRMD < H. pylori < NSAID (deepest)
list the causes of PUD in increasing order of ulcer depth
H. pylori
which cause of PUD is usually consistent with epigastric pain?
SRMD > NSAID > H. pylori
SRMD: more severe, superficial mucosal capillaries
NSAID: more severe, single vessel
H. pylori: less severe, single vessel
list the causes of PUD in decreasing order for incidence of GI bleeding
true
T/F: In the United States, H. pylori prevalence is approximately 30% to 40%, but it is much higher in adults older than 60 years (50%- 60%) than in children younger than 12 years (10%-15%).
Idiopathic (non-H. pylori, non NSAID peptic ulcer)
Hypersecretion of gastric acid (Zollinger Ellison syndrome)
Viral infections (cytomegalovirus)
Vascular insufficiency (crack cocaine associated)
Radiation therapy
Chemotherapy (hepatic artery infusions)
Infiltrating disease (Crohn's disease)
Roux-en-Y gastric bypass surgery
list some uncommon causes of chronic peptic ulcers
Cirrhosis
Chronic kidney disease
Chronic obstructive pulmonary disease
Cardiovascular disease
Organ transplantation
list some diseases and medical conditions associated with chronic peptic ulcer.
gastro-oral or fecal-oral contact
H. pylori is a spiral, microaerophilic, gram-negative bacteria with flagella. How is it tansmited from person to person?
1. close contact within household
2. low-income status
3. develeping countries
list some risk factors for H. pylori infection.
NSAID
- including low-dose Aspirin
chronic _____ use has been linked to PUD, gastritis, and superficial erosion.
- cause superficial mucosal damage petechia (intramucosal hemorrhages) within minutes of ingestion
- erosions occur with continued use
1. Age > 65
2. previous ulcer-related upper GI complications
3. high-dose NSAIDs
4. multiple NSAID use
5. selection of NSAID (COX 1 vs 2)
6. NSAID-related dyspepsia
7. H. pylori infections
8. cigarette smoking
9. alcohol consumption
10. chronic debilitating disorders: cardiovascular disease, RA
11. concomitant use of: low-dose Aspirin, oral bisphosphonates (Alendronate), systemic corticosteroids, anticoagulants or coagulopathy, antiplatelet drugs (Clopidogrel), SSRIs
list some risk factors with NSAID-induced ulcers.
reduced
Gastric ulcers usually have normal or _____ (elevated or reduced) acid secretion
1. pain 2-3 hours after a meal
2. food often relieves pain
3. nocturnal epigastric pain
what are some clinical presentations of duodenal ulcers?
no consistent pattern; food sometimes causes or accentuates pain
what are the clinical presentations of gastric ulcers?
upper GI bleeding
life-threatening PUD complication caused by erosion of ulcer into artery
- occurs in 26-59% of patients
- may be hidden
- may present as melena or hematemesis
- NSAID-use important risk factor
perforation into peritoneal cavity
second most common life-threatening PUD complication
- incidence have decreased due to PPI use
- older patient's prognosis is poo
- pain is sudden, sharp, and severe
obstruction
life-threatening PUD complication caused by narrowing of the duodenum due to chronic inflammation and scarring
- patient may experience severe vomiting and hematemesis
▪Bleeding/Anemia
▪Dysphagia
▪Odynophagia
▪Early satiety
▪Weight loss (unexplained)
▪Recurrent vomiting
▪Family history of GI cancer
what are some alarm symptoms of PUD?
low; positive
When testing for PUD, the hematocrit and hemoglobin are ____ with bleeding, and stool hemoccult tests are ______.
Histology: microbiologic examination [gold standard]
gold standard test for H. pylori; 95% sensitive and specific
- tests for active H. pylori infections
- allows for classification of gastritis
- no immediate results
- not recommended for initial diagnosis
culture of endoscopic biopsy
testing for H. pylori that enables sensitivity testing to determine appropriate treatment or antibiotic resistance; 100% specific
- results are not immediate
- not recommended for initial diagnosis
- used after failure of second-line treatments
- tests for active H. pylori infection
biopsy (rapid) urease
H. pylori urease generates ammonia, which causes a color change
- test of choice at endoscopy; greater than 90% sensitive and specific
- rapid results (usually within 24 hours)
- tests for active H. pylori infection
polymerase chain reaction
H. pylori DNA is detected in gastric tissue; this test is highly specific and sensitive; high rate of false positives and false negatives
- considered a research technique
antibody detection (laboratory based)
detects antibodies to H. pylori in serum using Laboratory based ELISA tests and latex agglutination techniques
- quantitative, less sensitive and specific than endoscopic tests
- more accurate than in office
- unable to determine if antibody is related to active or cured infection
- antibody titers vary markedly among individuals and take 6 months to 1 year to return to the uninfected range
- not affected by PPIs or bismuth
- antibiotics given for unrelated indications may cure the infection, but antibody test will remain positive
antibody detection (can be performed in office or near patient)
detects IgG antibodies to H. pylori in whole blood or finger stick
- qualitative; quick (within 15 min)
- unable to determine if antibody is related to active or cured infection
- most patients remain seropositive for at least 6 months to 1 year after H. pylori eradication
- not affected by PPIs, bismuth, or antibiotics
urea breath test
H. pylori urease breaks down ingested labeled C-urea, patient exhales labeled CO2
- Tests for active H. pylori infection;
- 95% sensitive and specific
- results take about 2 days
- antibiotics, bismuth, PPIs, and H2RAs may cause false negative results; withhold PPIs or H2RAs (12 weeks) and bismuth or antibiotics (4 weeks) prior to testing; recommended test to confirm post treatment eradication of H. pylori
fecal antigen
Identifies H. pylori antigen in stool by enzyme immunoassay using polyclonal anti-H. pylori antibody
- Tests for active H. pylori infection
- sensitivity and specificity comparable to urea breath test when used for initial diagnosis
- antibiotics, bismuth, and PPIs may cause false negative results, but to a lesser extent than with the urea breath test
- may be used post treatment to confirm eradication, but patients may have a reluctance to obtain stool samples
1. control stress
2. smoking cessation
3. avoid foods and beverages that cause dyspepsia: spicy, caffeine, alcohol
4. surgery for patients with ulcer-related complications
list some nonpharmacological treatment options for PUD.
- Established indications for the treatment of H. pylori
- Active PUD
- Past history of PUD (unless eradication previously documented)
- MALT lymphoma
- After endoscopic resection of gastric cancer
List some indications for pharmacological treatment of H. pylori infection.
1. Individuals with functional dyspepsia
2. GERD
3. Unexplained iron deficiency anemia
4. Idiopathic thrombocytopenic purpura
5. Individuals taking long-term low-dose aspirin
6. Initiating chronic treatment with NSAID
7. Individuals at high risk for gastric cancer
List some controversial indications for the treatment of H. pylori infection
Bismuth quadruple therapy and concomitant (non-bismuth quad) therapy
initial treatment of H. pylori infection
- both administered for 10-14 days
bismuth quadruple therapy is the preferred initial treatment
What is the preferred initial treatment in patients allergic to penicillin who need to be treated for H. pylori?
1. PPI or H2RA: once or twice daily
2. Bismuth subsalicylate 525 mg QID
3. Metronidazole: 250-500 mg QID
4. Tetracycline 500 mg QID
Duration: 10-14 days
List the components and duration of the Bismuth quadruple regimen for H. pylori
1. PPI once or twice daily
2. Clarithromycin 250-500 mg BID
3. Amoxicillin 1 g BID
4. Metronidazole 250-500 mg BID
Duration: 10-14 days
List the components and duration of the Non-bismuth quadruple regimen for H. pylori
Clarithromycin, amoxicillin metronidazole, and tetracycline
list the antibiotics with high activity against H. pylori.
- single antibiotic therapy as a higher rate of resistance
PPI triple
alternative initial therapy that remains an option where clarithromycin resistance < 15% and no prior macrolide exposure documented
- No longer indicated in north America due to resistance rates
Sequential antibiotic therapy
- Antibiotic are administered in a sequence rather than together
- Basis is initial treatment with amoxicillin (rarely has resistance) to reduce bacteria load of resistant organisms
- Second sequence with different antibiotic (clarithromycin and metronidazole) to kill rest of bacteria
- Requires switching Abx which contributes to nonadherence
Dual therapy
- Gaining consideration due to increase resistance to common regimens
- Uses high doses of PPI and amoxicillin (inactivated at low pH)
- Usually results in similar eradication rates as first-line therapy
hybrid therapy
- Combines concomitant and sequential therapy
- First-line alternative to clarithromycin triple therapy (but lacks evidence in North America
Levofloxacin-based therapy
Is first-line salvage therapy but evidence is scarce for first-line treatment
LOAD
Is not recommended within guidelines due to cost and lack of data
- Concerns also with resistance and ADR (tendonitis and hepatotoxicity)
Vonoprazan-based regimens
the first potassium-competitive acid blocker (PCABs); inhibits H+/K+ ATPase via a competitive interaction with the K+ site of the enzyme resulting in pronounced and durable acid suppression within 4 hours.
- Acid suppression more potent and H. pylori eradication rates higher vs PPI-based triple therapy regimen
Bismuth quadruple therapy or levofloxacin regimens are preferred
For eradication of H. pylori after initial treatment failure, if the patient received initial treatment with Clarithromycin, what is the preferred therapy?
Clarithromycin or levofloxacin containing regimens are preferred
For eradication of H. pylori after initial treatment failure, if patients received initial treatment with Bismuth quadruple therapy, what should be given?
8 week regimen; H2RA, PPI, or Sucralfate
NSAID therapy should be stopped upon confirmation of an active ulcer. Once stopped, uncomplicated ulcers heal with standard ____ week therapy regimen with:
antibody detection (laboratory based)
d